Trending News
News
News
New Peptide Could Combat the Cause of Familial Hypercholesterolemia
A new peptide is being developed and tested with hopes that it will lead to better treatment options for familial hypercholesterolemia. There are two forms of FH: heterozygous FH (HeFH) and homozygous HoFH, which is the most serious type of FH. If untreated, HoFH often causes heart disease in the early teen years and sometimes even in early childhood.
News
Marijuana Sales Creating Damage to the Environment
In a publication by the journal Environmental Science and Technology, researchers have called on U.S. federal agencies to fund studies that will gather essential environmental data from the legal cultivation farms and facilities.
News
Measuring Reactions at the Single Molecule Level
DNA, the stuff of life, may very well also pack quite the jolt for engineers trying to advance the development of tiny, low-cost electronic devices.
News
100 Years on the "WarBurg Effect" Proves Fundamental in Cancer
First observed in the 1920's, the "WarBurg Effect" is of fundamental importance to the development of aggressive tumors.
News
What's in a GENRE?
In silico predictive toxicogenomic models of species-specific differences between rat and humans from genome-scale reconstructions (GENREs).
News
Sequence of Exposure to Pesticides and Pollutants Affects Levels of Toxicity
Exposure to pesticides and pollutants not just the dosage significantly affects the levels of toxicity for surrounding wildlife.
Sequence of exposure to pesticides and pollutants affects levels of toxicity for wildlife.
Sequence of exposure to pesticides and pollutants affects levels of toxicity for wildlife.
News
Insecticides Bind Melatonin Receptors, Altering Circadian Rhythms
University at Buffalo researchers describe how synthetic chemicals commonly found in insecticides alter sleep-wake patterns.
News
Where Do Honey Bees Come From?
Insight into honey bee origins could be useful for breeding bees resistant to disease or pesticides.
News
New Hope for Huntington’s Treatment
Study opens the way for new approaches to treating the currently untreatable and deadly neurodegenerative disease.
News
Boosting the Efficacy of A Key Cancer Treatment
Unfortunately, only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.
Advertisement